Are Pot Stocks Getting Cheaper?

Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) is looking like a good buy compared to some of its peers.

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

Cannabis investors have been paying some big premiums in recent years to own stocks that offered little in the way of earnings and just relied on promises of future growth. However, now that we’ve seen marijuana companies start to report some strong sales numbers, those valuations might not be as astronomical as they once were. Let’s take a look at some of the bigger names in the industry to see if that’s really the case today.

Aurora Cannabis (TSX:ACB)(NYSE:ACB) had sales grow to $54 million in its most recent quarter, which was more than four times the revenue it had a year ago. That put its sales for the trailing 12 months at $119 million. With a market cap of $12 billion, that puts the stock at a price-to-sales (P/S) ratio of around 100.

Back in June of last year, I had noted that Aurora was trading well over a P/S of 100 and that was only because it had been declining at that point. In Aurora’s case, its valuation has certainly come down, despite the fact that its share price has risen 45% since then. Rising sales have contributed to the lower P/S ratio, and that’s a trend that’s likely to continue as we see companies report post-legalization sales that are sure to send their top lines soaring.

In its most recent earnings, Aurora still didn’t include a full three months of recreational sales, so in its next earnings release we’ll likely see an even stronger revenue number. While it’s still an expensive stock, we can definitely see that its valuation has improved since last year.

Cronos Group (TSX:CRON)(NASDAQ:CRON) is another expensive pot stock, which was trading at more than 250 times its sales back in December. Since then, its share price has risen by more than 80%, and that’s after it has come down in price in the past month. For Cronos, the company’s results have not kept up with its rising sharing price.

Over its past four quarters, sales have totalled just $16 million. And with a market cap of $7.5 billion, investors are paying a mammoth 480 times the company’s sales. Cronos was an expensive stock back in December and things have only gotten worse since then. While the stock might have some great prospects for growth, investors might be wise to wait until some of that is realized before jumping on board.

Cronos is heavily overvalued even compared to other pot stocks. It would have to see a significant decline in price for it to be comparable to one like Aurora which has much more substance behind its share price.

Bottom line

Pot stocks are still very expensive. And while Aurora may have come down in price in the past year, paying even 10 times sales is still a lot for a stock. However, the good news is that at least in Aurora’s case, the multiple is going in the right direction. Although there is some semblance that prices are coming down to reality, you’ve still got stocks like Cronos that have reached even more obscene levels.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

Why Canopy Growth Stock Jumped 16% on Wednesday

Canopy Growth stock (TSX:WEED) is up 16% on Wednesday, adding to a surge of 60% growth in the last week…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Is the Worst Over for Canopy Growth Stock?

Down 99% from all-time highs Canopy Growth stock has burnt investor wealth and remains a high-risk investment.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Steer Clear: This Stock Spells Trouble

A newly listed cannabis stock is outperforming in 2024 but investors should stay clear to avoid trouble and losses.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

2 Best Marijuana Stocks to Buy This Month

Marijuana stocks in the U.S. such as Green Thumb and Curaleaf can help you deliver outsized gains to investors in…

Read more »

A cannabis plant grows.
Cannabis Stocks

Can Aurora Cannabis Stock Recover in 2024?

Aurora Cannabis stock is down 99% from all-time highs but remains a high-risk bet, despite its cheap valuation.

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

The Best Cannabis Stock to Buy Right Now

This cannabis stock has jumped 30% in the last few months, with even more growth on the way – all…

Read more »